Project Grant HT9425261E401
Award Date 9/1/26
Completion Date 8/31/29
Dollars Obligated $293K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Tampa, FL 33612, USA
Similar Awards
- Federal Grant Award Summary H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received a $968,875 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2028. The award funds research to identify and assess immunotherapy targets in neurofibromatosis type 2 (NF2)-associated schwannomatosis, a rare genetic disorder characterized by the development of multiple...
- Federal Grant Award Summary H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received a $397,788 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2026, through May 31, 2029. The award supports research investigating age-driven metastatic vulnerabilities in triple-negative breast cancer, with performance activities conducted at the center's Tampa, Florida facility. This research...
- Federal Project Grant Award Summary H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received a $2.1M Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period June 1, 2026 through May 31, 2029. The grant funds research addressing "Targeting Age-Driven Metastatic Vulnerabilities in Triple-Negative Breast Cancer," with work performed at the center's Tampa, Florida facility. This...
- Grant Award Summary H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received a $1,124,896 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on July 15, 2025, for a four-year performance period concluding July 14, 2029. The award funds research characterizing the role of aberrant FGD1 (FYVE, RhoGEF and PH Domains-containing Protein 1) splicing in brain and bone metastasis in clear cell renal cell...
- Federal Grant Award Summary H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received a $459,360 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct research on genetic risk factors associated with prostate cancer in self-identified Black veterans. The three-year award, which commenced July 1, 2025 and concludes June 30, 2028, supports hypothesis-driven biomedical research aimed at advancing...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded MD Anderson Cancer Center a $1.4 million Project Grant on September 16, 2026, under the Military Medical Research and Development program (CFDA 12.420) to support translational therapeutics research focused on accelerating the discovery and clinical application of cancer treatments, with particular emphasis on pancreatic cancer. The three-year award, extending through September 2029, funds basic and applied biomedical research...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $352,000 under the Military Medical Research and Development program (CFDA 12.420) to the Sloan-Kettering Institute for Cancer Research for the project period September 1, 2025, through August 31, 2027. The award supports research focused on augmenting the in vivo efficacy of a novel lanosterol synthase inhibitor in glioblastoma treatment. This research aligns with the DHA's mission to transform healthcare for service...
- This $1,619,065.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the "DYNAMIC: DEVELOPMENT OF A BEHAVIORAL INTERVENTION FOR YOUNG ADULTS WITH ADVANCED CANCER" project. The grant, awarded on April 15, 2025, provides funding to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., a National Cancer Institute-designated comprehensive cancer center in Tampa, Florida, to develop an...
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received a $798,673 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on July 15, 2025, with an ultimate completion date of June 14, 2029. The award funds research to characterize the role of aberrant FGD1 splicing in brain and bone metastasis in clear cell renal cell carcinoma. This research aims to advance understanding of metastatic mechanisms...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded MD Anderson Cancer Center a Project Grant of $559,463 under the Military Medical Research and Development program (CFDA 12.420) for the period August 1, 2026 through July 31, 2028. The award supports research investigating "Alternating Clonal Dominance and Local Microenvironment Evolution at the Primary Tumor Site as Key Drivers of Metastatic Dissemination in Pancreatic Cancer." This research addresses...